loader2
Partner With Us NRI

Lyka Labs Ltd share Price Today

Company details

110.68
114.00
97.90
144.30
6M Return -10.39%
1Y Return 2.26%
Mkt Cap.(Cr) 402.19
Volume 79,374
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 79,374

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

Lyka Labs Ltd shares SWOT Analysis

Strengths (6)

  • Growth stocks, promoters increasing shareholding
  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
  • Book Value per share Improving for last 2 years

Weakness (4)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
  • Low Piotroski Score : Companies with weak financials

Opportunity (2)

  • Stock with Low PE (PE < = 10)
  • RSI indicating price strength

Threats (0)

Data not found

Resistance and support

R1 114.2
R2 115.8
R3 117.6
Pivot

112.46

S1 110.9
S2 109.1
S3 107.6
EMA SMA
109.6
111.1
113.9
116.1
108.7
110.4
115.4
118.2
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
QUANT MUTUAL FUND QUANT SMALL CAP FUND Bulk Sell 2023-06-02 101.93 150000 NSE
PRABHULAL LALLUBHAI PAREKH Bulk Purchase 2023-05-26 91.97 185061 NSE
PRABHULAL LALLUBHAI PAREKH Bulk Sell 2023-05-26 92.61 168148 NSE
Name Category Shares
KUNAL NARENDRA GANDHI PROMOTER 6.79%
NEHAL NARENDRA GANDHI PROMOTER 6.53%
PRANAY GODHA PROMOTER 0.84%
IPCA LABORATORIES LIMITED PROMOTER 40.98%
ENAI TRADING AND INVESTMENT PVT. LTD PROMOTER 2.8%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Lyka Labs Ltd Stocks COMPARISON

Financials( in Cr) Lyka Labs Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Divis Laboratories Ltd Zydus Lifesciences Ltd
Price 112.69 1,577.30 1,512.05 4,539.30 1,175.15
% Change 2.31 -1.33 -0.08 -2.11 -0.42
Mcap Cr 402.19 378,447.11 122,077.93 120,504.34 118,247.59
Revenue TTM Cr 93.07 48,496.85 15,790.60 7,767.51 19,547.40
Net Profit TTM Cr -13.15 9,648.44 2,513.47 1,823.38 3,854.40
PE TTM 0.00 37.90 28.67 75.30 30.67
1 Year Return 2.26 50.94 48.72 24.71 102.05
ROCE 0.00 17.20 14.76 19.30 23.94
ROE 0.00 16.13 10.66 14.89 20.64
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 29.08 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 22,015.43 44,980.72
LAST 3M 106,765.53 41,611.09
LAST 6M 195,525.59 13,104.33
LAST 12M 310,530.02 79,314.43
Lyka Labs Limited - Updates

Jul 12, 2024 l NSE Announcement

Lyka Labs Limited - Updates

Jul 11, 2024 l NSE Announcement

Lyka Labs Limited - Loss of Share Certificates

Jul 10, 2024 l NSE Announcement

Date Action Type Ratio
No data found

Lyka Labs Ltd Information

Stock PE (TTM)
0
Promoter Holding
58.1%
Book Value
19.8235
ROCE
0%
ROE
0%
Description
  • Initially manufacturing formulations, Lyka Labs brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. `83. It also added a range of ayurvedic and animal health care products over the years. In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, Denmark; and Terumo Corporation, Japan. Lyka Exports is the subsidiary of the company. The company offers a broad range of antibiotics used as life-savers and to treat minor infections. It has a fairly widespread product base with tropical steroids for skin disorders, anti-cancer products, cardio-vascular drugs and anti-inflammatory products. Lyka introduced, in India, cough lozenges containing dextromethorphan hydrobromide (DMR), favoured internationally as an effective and safe cough suppressant. Lyka has two formulations division and a bulk drugs division. It also set up additional manufacturing facilities for ointments. As part of its diversification, it has invested in Relic Finance, a company carrying on the business of finance and merchant banking. A GOI-recognised Export House, it received the Certificate of Merit for its excellent export performance in 1993-94. In the same year, it received an award from CHEMEXCIL for its outstanding performance. During 1997-98, the company`s administrative office & plant at tarapur has been awarded ISO 9002 certification for its quality management system by SGS Yarsley International Certification Services Limited, UK. The production carried out at Bombay has been shifted to Tarapur and Ankleshwar in the year 1999-2000, inorder to achieve economies of scale and better compliance. The company has assigned Trade Marks and transferred technical, marketing know-how and allied rights pertaining to some of its products. The Company`s factory at Tarapur, re-commissioned production in March, 2013. It launched Glutathione Injection, a "First Time in India" formulation during 2012-13. It commissioned the production at Ankleshwar factory. During Financial Year 2013-14, the Company had floated a Wholly Owned Subsidiary Company namely Lyka Healthcare Limited to focus, develop and expand Domestic Marketing of Ethical Products. Its another subsidiary, Lyka Exports Limited reorganized its activities and resultant, it sold the Animal Healthcare Business in 2014. The subsidiaries, Lyka Healthcare Limited and Lyka Exports Limited merged with the Company which became effective from April 01, 2016. During the year 2021-22, IPCA together with persons acting in concert acquired 26.70% shares of the Company through Public Offer consisting a total shareholding of 27.76% of the Paid-up Equity Capital of the Company and resultant to acquisition in stake, became the Joint Promoters of Company.

Registered Address

4801/B & 4802/A, GIDC Industrial Estate, Ankleshwar, Gujarat, 393002

Tel : 91-02646-221422/220549
Email : investorredressal:lykalabs.com; enquiry:lykalabs.c
Website : http://www.lykalabs.com
Registrar

Sharex Dynamic (India) Pvt Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 500259
NSE Code : LYKALABS
Book Closure Date (Month) : Jul/Aug
BSE Group : B
ISIN : INE933A01014

FAQ’s on Lyka Labs Ltd Shares

You can buy Lyka Labs Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Lyka Labs Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jul 12, 2024 04:04 PM the closing price of Lyka Labs Ltd was Rs.112.69.

The latest PE ratio of Lyka Labs Ltd as of Jul 12, 2024 04:04 PM is 0.00

The latest PB ratio of Lyka Labs Ltd as of Jul 12, 2024 04:04 PM is 0.18

The 52-week high of Lyka Labs Ltd share price is Rs. 144.30 while the 52-week low is Rs. 97.90

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jul 12, 2024 04:04 PM, the market cap of Lyka Labs Ltd stood at Rs. 402.19 Cr.

Download App

Download Our App

Play Store App Store
market app